octanine f 500 ui
octapharma (ip) ltd. - factor ix de coagulare - pulb. + solv. pt. sol. perf. - 500 ui - vitamina k si alte hemostatice factori ai coagularii sanguine
octanine f 1000 ui
octapharma (ip) ltd. - factor ix de coagulare - pulb. + solv. pt. sol. perf. - 1000ui - vitamina k si alte hemostatice factori ai coagularii sanguine
octanate 50 ui/ml
octapharma (ip) ltd. - factor viii de coagulare - pulb. + solv. pt. sol. inj. - 50ui/ml - vitamina k si alte hemostatice factori ai coagularii sanguine
octanate 100 ui/ml
octapharma (ip) ltd. - factor viii de coagulare - pulb. + solv. pt. sol. inj. - 100ui/ml - vitamina k si alte hemostatice factori ai coagularii sanguine
wilate 500 500 ui fvw/500 ui fviii
octapharma (ip) ltd. - factor viii de coagulare si factor von willebrand - pulb+solv. pt. sol. inj - 500 ui fvw/500 ui fviii - vitamina k si alte hemostatice factori ai coagularii sanguine
wilate 1000 1000 ui fvw/1000 ui fviii
octapharma (ip) ltd. - factor viii de coagulare si factor von willebrand - pulb+solv. pt. sol. inj - 1000 ui fvw/1000 ui fviii - vitamina k si alte hemostatice factori ai coagularii sanguine
octanate lv 100 ui/ml
octapharma (ip) ltd. - factor viii de coagulare - pulb+solv. pt. sol. inj. - 100ui/ml - vitamina k si alte hemostatice factori ai coagularii sanguine
octanate lv 200 ui/ml
octapharma (ip) ltd. - factor viii de coagulare - pulb+solv. pt. sol. inj. - 200ui/ml - vitamina k si alte hemostatice factori ai coagularii sanguine
combivir
viiv healthcare bv - lamivudină, zidovudină - infecții cu hiv - antivirale pentru uz sistemic - combivir is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection.
tivicay
viiv healthcare bv - dolutegravir - infecții cu hiv - antivirale pentru uz sistemic - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.